KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amgen (AMGN) Finished Goods (2016 - 2017)

Amgen (AMGN) has 5 years of Finished Goods data on record, last reported at $1.1 billion in Q2 2017.

  • For Q2 2017, Finished Goods changed N/A year-over-year to $1.1 billion; the TTM value through Jun 2017 reached $1.1 billion, changed N/A, while the annual FY2016 figure was $912.0 million, 29.36% up from the prior year.
  • Finished Goods reached $1.1 billion in Q2 2017 per AMGN's latest filing, down from $1.2 billion in the prior quarter.
  • Across five years, Finished Goods topped out at $1.2 billion in Q1 2017 and bottomed at $705.0 million in Q4 2015.
  • Average Finished Goods over 5 years is $920.5 million, with a median of $914.0 million recorded in 2014.
  • Peak YoY movement for Finished Goods: fell 21.49% in 2015, then skyrocketed 48.02% in 2017.
  • A 5-year view of Finished Goods shows it stood at $738.0 million in 2013, then increased by 21.68% to $898.0 million in 2014, then dropped by 21.49% to $705.0 million in 2015, then increased by 29.36% to $912.0 million in 2016, then rose by 21.27% to $1.1 billion in 2017.
  • Per Business Quant database, its latest 3 readings for Finished Goods were $1.1 billion in Q2 2017, $1.2 billion in Q1 2017, and $912.0 million in Q4 2016.